What Makes Madrigal Pharma (MDGL) One of the Shorted Biotech Stocks to Buy

On February 20, Bank of America Securities lowered the terms people connected Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) from $570 to $529, resulting successful upside imaginable supra 22%. The steadfast maintained its Neutral standing connected the stock.

Following the company’s quarterly results and the associated call, the steadfast modestly lowered its fiscal forecasts. The accommodation incorporates management’s comments regarding gross-to-net adjustments.

Back connected February 19, Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) reported Q4 EPS of $2.57 with gross of $321.083 million, modestly supra consensus. Bill Sibold, Chief Executive Officer of Madrigal, stated:

“2025 marked a defining twelvemonth for Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL). We solidified our presumption arsenic the undisputed person successful MASH highlighted by astir $1 cardinal successful Rezdiffra income successful its archetypal afloat twelvemonth of launch. And we’re conscionable getting started – having penetrated lone a fraction of a marketplace that we judge has decades of maturation ahead. We judge 2026 volition beryllium adjacent much breathtaking wherever we expect different twelvemonth of robust nett income maturation driven by wide first-line access, expanding illness consciousness and the outstanding real-world acquisition with Rezdiffra reported by patients and providers.”

Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is simply a biopharmaceutical institution with a crisp absorption connected tackling a superior and underserved liver illness called MASH. Their flagship product, Rezdiffra, works straight connected the liver to code the basal causes of the condition, offering patients much-needed attraction successful an country wherever effectual therapies person agelong been lacking.

While we admit the imaginable of MDGL arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 12 Oversold Financial Stocks to Invest successful According to Hedge Funds.

Disclosure: None. Follow Insider Monkey connected Google News.